Pfizer CEO scored big raise—to $24M—as drugmaker played a leading role in pandemic fightnews2022-03-18T18:40:40+00:00March 18th, 2022|Fierce Pharma|
Pfizer gets an A on equality scorecard on Equal Pay Daynews2022-03-18T16:06:18+00:00March 18th, 2022|Fierce Pharma|
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submissionnews2022-03-18T15:16:05+00:00March 18th, 2022|Fierce Pharma|
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analystnews2022-03-18T14:35:23+00:00March 18th, 2022|Fierce Pharma|
Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovidnews2022-03-18T13:33:58+00:00March 18th, 2022|Fierce Pharma|
Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lillynews2022-03-18T10:28:46+00:00March 18th, 2022|Fierce Pharma|
Pharma’s ‘superhero’ image fades as inflation, Ukraine drown out the industrynews2022-03-18T08:44:27+00:00March 18th, 2022|Fierce Pharma|
Amid sales slump, Teva CEO Schultz’s pay falls 7% to $14.7Mnews2022-03-17T23:38:46+00:00March 17th, 2022|Fierce Pharma|
Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriqnews2022-03-17T15:52:59+00:00March 17th, 2022|Fierce Pharma|
GlaxoSmithKline wraps up Shingrix recall after inspection flagged cracked vialsnews2022-03-17T15:50:00+00:00March 17th, 2022|Fierce Pharma|
